DK0572425T3 - Imidazopyridin-PAF/H1-antagonister - Google Patents

Imidazopyridin-PAF/H1-antagonister

Info

Publication number
DK0572425T3
DK0572425T3 DK92902889.2T DK92902889T DK0572425T3 DK 0572425 T3 DK0572425 T3 DK 0572425T3 DK 92902889 T DK92902889 T DK 92902889T DK 0572425 T3 DK0572425 T3 DK 0572425T3
Authority
DK
Denmark
Prior art keywords
pct
paf
antagonists
sec
imidazopyridine
Prior art date
Application number
DK92902889.2T
Other languages
Danish (da)
English (en)
Inventor
David Alker
Robert John Bass
Kelvin Cooper
Original Assignee
Pfizer
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Pfizer Ltd filed Critical Pfizer
Application granted granted Critical
Publication of DK0572425T3 publication Critical patent/DK0572425T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Prostheses (AREA)
DK92902889.2T 1991-02-13 1992-01-24 Imidazopyridin-PAF/H1-antagonister DK0572425T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
DK0572425T3 true DK0572425T3 (da) 1994-09-12

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92902889.2T DK0572425T3 (da) 1991-02-13 1992-01-24 Imidazopyridin-PAF/H1-antagonister

Country Status (29)

Country Link
US (1) US5358953A (enExample)
EP (1) EP0572425B1 (enExample)
JP (1) JP2506541B2 (enExample)
KR (1) KR970005302B1 (enExample)
CN (1) CN1040326C (enExample)
AT (1) ATE109482T1 (enExample)
AU (1) AU650322B2 (enExample)
BR (1) BR9205615A (enExample)
CA (1) CA2099381C (enExample)
CZ (1) CZ280504B6 (enExample)
DE (1) DE69200304T2 (enExample)
DK (1) DK0572425T3 (enExample)
EG (1) EG20085A (enExample)
ES (1) ES2059212T3 (enExample)
FI (1) FI933531A7 (enExample)
GB (1) GB9102997D0 (enExample)
HU (2) HUT65947A (enExample)
IE (1) IE65125B1 (enExample)
IL (1) IL100887A (enExample)
MX (1) MX9200589A (enExample)
MY (1) MY108437A (enExample)
NO (1) NO300592B1 (enExample)
NZ (1) NZ241597A (enExample)
PL (1) PL169304B1 (enExample)
RU (1) RU2114845C1 (enExample)
TW (1) TW227000B (enExample)
WO (1) WO1992014734A1 (enExample)
YU (1) YU48238B (enExample)
ZA (1) ZA921005B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
EP0775139A1 (en) * 1994-08-10 1997-05-28 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
BR9609892A (pt) * 1995-08-05 1999-05-25 British Biotech Pharm Derivados de imidazopiridina
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
PT1311269E (pt) 2000-08-04 2012-05-10 Dmi Biosciences Inc Método de utilização de dicetopiperazinas e composição que contém as mesmas
ES2575563T3 (es) 2003-05-15 2016-06-29 Ampio Pharmaceuticals, Inc. Tratamiento de enfermedades mediadas por los linfocitos T
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
BRPI0821909A2 (pt) 2008-01-30 2018-07-17 Nippon Zoki Pharmaceutical Co., Ltd. derivado de piperidina
EP2300011A4 (en) 2008-05-27 2012-06-20 Dmi Life Sciences Inc THERAPEUTIC PROCESSES AND COMPOUNDS
JP5978296B2 (ja) * 2011-06-28 2016-08-24 フジアン・ミンドン・レジュヴネイション・ファーマスーティカル・カンパニー・リミテッド 抗アレルギ性ベンゾシクロヘプタチオフェン誘導体
SG10201608087WA (en) 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
SG10201608103YA (en) 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Treatment of degenerative joint disease
CA2846394A1 (en) * 2011-10-28 2013-05-02 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
WO2014145729A2 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
EP3183240A4 (en) 2014-08-18 2018-06-27 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
HK1246669A1 (zh) 2015-06-22 2018-09-14 Ampio Pharmaceuticals, Inc. 人血清白蛋白低分子量组分在疾病治疗中的应用
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (enExample) * 1963-04-24
WO1989008653A1 (en) * 1988-03-15 1989-09-21 G.D. Searle & Co. 1H/3H-[4-(N,N-DICYCLOALKYL/BRANCHED-ALKYLCARBOXAMIDO)-BENZYL]IMIDAZO[4,5-c]PYRIDINES AS PAF ANTAGONISTS
NZ228889A (en) * 1988-04-28 1991-09-25 Schering Corp Fused tri- or tetracyclic heterocyclic compounds and pharmaceutical compositions
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
AU642265B2 (en) * 1990-05-09 1993-10-14 Pfizer Inc. Imidazo (4,5-c) pyridines with PAF antagonist activity

Also Published As

Publication number Publication date
IL100887A (en) 1996-01-19
ES2059212T3 (es) 1994-11-01
AU1168392A (en) 1992-09-15
FI933531A0 (fi) 1993-08-10
NO932889L (no) 1993-08-13
YU48238B (sh) 1997-08-22
IL100887A0 (en) 1992-11-15
CA2099381A1 (en) 1992-08-14
BR9205615A (pt) 1994-05-17
PL169304B1 (pl) 1996-06-28
CA2099381C (en) 1996-07-09
RU2114845C1 (ru) 1998-07-10
FI933531L (fi) 1993-08-10
WO1992014734A1 (en) 1992-09-03
ATE109482T1 (de) 1994-08-15
AU650322B2 (en) 1994-06-16
TW227000B (enExample) 1994-07-21
CS42592A3 (en) 1992-09-16
JP2506541B2 (ja) 1996-06-12
HU9302327D0 (en) 1993-10-28
GB9102997D0 (en) 1991-03-27
FI933531A7 (fi) 1993-08-10
DE69200304T2 (de) 1994-12-08
ZA921005B (en) 1993-08-12
HU211202A9 (en) 1995-11-28
IE65125B1 (en) 1995-10-04
NZ241597A (en) 1993-04-28
EP0572425A1 (en) 1993-12-08
NO300592B1 (no) 1997-06-23
MY108437A (en) 1996-09-30
CN1064275A (zh) 1992-09-09
DE69200304D1 (de) 1994-09-08
EP0572425B1 (en) 1994-08-03
US5358953A (en) 1994-10-25
IE920449A1 (en) 1992-08-12
JPH06504992A (ja) 1994-06-09
CN1040326C (zh) 1998-10-21
HUT65947A (en) 1994-08-29
EG20085A (en) 1997-05-31
CZ280504B6 (cs) 1996-02-14
KR970005302B1 (ko) 1997-04-15
YU14392A (sh) 1994-11-15
NO932889D0 (no) 1993-08-13
MX9200589A (es) 1992-10-01

Similar Documents

Publication Publication Date Title
DE69200304D1 (de) Imidazopyridin-PAF/H1-Antagonisten.
YU48426B (sh) Novi supstituisani pirazolilpirazoli, postupak njihovog dobijanja, medjuproizvodi za njihovo dobijanje i primena kao sredstava sa herbicidnim delovanjem
ES2162061T3 (es) Derivados de piperidina como antagonistas de la neuroquinina.
ES2167371T3 (es) Derivados de 1h-3-aril-pirrolidin-2,4-diona espirociclicos substituidos.
YU84791A (sh) Biciklicni 1-aza-cikloalkalni
HRP941000B9 (hr) Morfolin i tiomorfolin antagonisti receptora tahikinina
PE20050080A1 (es) Antagonistas del receptor opioide
RU93054165A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция, способ лечения
CO4410319A1 (es) Derivados de fenetanolamina
FI922341A0 (fi) Piperidin- och pyrrolidinderivat.
MX9300312A (es) Antagonistas benzopiranicos y relacionado de ltb.
SG164268A1 (en) Quinolin-4-yl derivatives i
UA41350C2 (uk) Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі
YU4393A (sr) Supstituisani heksahidroazepinoni i tetrahidrobenzazepinoni
ES2095995T3 (es) Procedimiento para la obtencion de 2,2-difluorbenzo(1,3)dioxol-carbaldehidos y nuevos productos intermedios.
MX9606654A (es) Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina.
SE7609222L (sv) Alkylsulfonylaminosubstituerade heterocykler
FI973558L (fi) Menetelmä terapeuttisesti käytt¦kelpoisten 2-metyyli-imidatsoÄ4,5-cÜpyrid-1-yylijohdannaisten valmistamiseksi
ATE62131T1 (de) Pharmazeutische zusammenstellung fuer die prophylaxe oder behandlung von tierhaltungsketose.
FI900650A0 (fi) Kalciumantagonister.
PT100223A (pt) Processo para a preparacao de imidazopiridinas antagonistas de paf/h1
ES2084547B1 (es) Antagonistas benzopiranicos y relacionados de leucotrieno b4.
SE8301039D0 (sv) Heterocykliska derivat
ECSP003687A (es) Derivados 1 de quinolin-4- il
YU164891A (sh) Zasićene hidroksialkilhinolin kiseline kao antagonisti leukotriena